Format

Send to

Choose Destination
J Clin Invest. 2005 Jan;115(1):25-7.

Immune complexes as therapy for autoimmunity.

Author information

1
Department of Medicine and Microbiology, Columbia University, New York, New York 10032, USA. rc645@columbia.edu

Abstract

For several decades, intravenous Ig has been used as treatment for a variety of immune-related diseases, including immune thrombocytopenic purpura (ITP), autoimmune neuropathies, systemic lupus erythematosus, myasthenia gravis, Guillain-Barré syndrome, skin blistering syndromes, and Kawasaki disease. Despite years of use, its mechanism of immunomodulation is still unclear. Recent studies using mouse models of ITP and arthritis, including one reported in this issue of the JCI, now provide some insights into this mechanism and the rationale for the development of Fcgamma receptor-targeted therapeutics.

PMID:
15630438
PMCID:
PMC539209
DOI:
10.1172/JCI23994
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center